Abstract
We describe the surveillance strategies after esophageal cancer treatment, whether local therapy, induction chemoradiation, or other definitive treatment such as trimodality therapy. We discuss the shortcomings of the different invasive and imaging studies, and the recommended stage-specific surveillance after local and organ-sparing approaches to esophageal cancer treatment.
Keywords:
Chemoradiation; Endoscopic resection; Neoadjuvant; Outcomes; Salvage esophagectomy.
Copyright © 2021 Elsevier Inc. All rights reserved.
MeSH terms
-
Adenocarcinoma / diagnosis*
-
Adenocarcinoma / pathology
-
Adenocarcinoma / therapy
-
Aftercare / methods*
-
Carcinoma, Squamous Cell / diagnosis*
-
Carcinoma, Squamous Cell / pathology
-
Carcinoma, Squamous Cell / therapy
-
Chemoradiotherapy*
-
Esophageal Neoplasms / diagnosis*
-
Esophageal Neoplasms / pathology
-
Esophageal Neoplasms / therapy
-
Esophagectomy
-
Esophagoscopy
-
Humans
-
Neoadjuvant Therapy
-
Neoplasm Metastasis
-
Neoplasm Recurrence, Local / diagnosis*
-
Neoplasm Recurrence, Local / pathology
-
Neoplasm Recurrence, Local / therapy
-
Neoplasm Staging
-
Neoplasm, Residual